Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mogamulizumab × Lymphoid × Clear all

Phase

Status

Completed 10 Recruiting 9 Active not recruiting 3 Terminated 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mycosis Fungoides 1

Interventions

Cyclophosphamide 28 Rituximab 20 zanubrutinib 19 blinatumomab 14 Vincristine 14 venetoclax 13 Prednisone 13 obinutuzumab 12 fludarabine 12 Specimen Handling 12 Magnetic Resonance Spectroscopy 11 Doxorubicin 10 Bendamustine Hydrochloride 10 glofitamab 9 Lenalidomide 9 Immunotherapy, Adoptive 9 Methotrexate 8 Cytarabine 8 Biopsy 8 polatuzumab vedotin 7 Dexamethasone 7 Prednisolone 5 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5 tislelizumab 4 pegaspargase 4 Whole-Body Irradiation 4 Therapeutics 4 Radiotherapy 4 Azacitidine 4 selinexor 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529405 2026-04-14

CurbMF

Virogen Biotechnology Inc.

Phase 2 Not yet recruiting

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon ⚡